AARDVARK THERAPEUTICS, INC. Accounts Payable
AARDVARK THERAPEUTICS, INC. (AARD) had Accounts Payable of $2.09 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-11
- 2026-06-30: Accounts Payable, Current $2.09M.
- 2026-03-31: Accounts Payable, Current $4.49M.
- 2025-12-31: Accounts Payable, Current $2.07M.
- 2025-09-30: Accounts Payable, Current $4.44M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $2.09M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $4.49M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.07M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $4.44M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.06M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.56M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $2.30M 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |